12 results on '"Padoan, R"'
Search Results
2. POS0326 COMPARATIVE EFFICACY OF MEPOLIZUMAB 100 MG, MEPOLIZUMAB 300 MG AND BENRALIZUMAB 30 MG IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A MONOCENTRIC RETROSPECTIVE OBSERVATIONAL STUDY
3. AB1258 EFFECTIVENESS OF DUPILUMAB ON REFRACTORY CHRONIC RHINOSINUSITIS WITH NASAL POLYPS IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A CLINICAL AND CYTOLOGICAL STUDY
4. AB1261 AVACOPAN IN THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS: MULTICENTER PROSPECTIVE REAL-LIFE STUDY ON EFFICACY, SAFETY, AND IMPACT ON QUALITY OF LIFE
5. POS1011 ABNORMALITIES IN CIRCULATING POLYMORPHONUCLEAR CELLS IN ANCA-ASSOCIATED VASCULITIS
6. AB0771 FEMALE GENDER AND STEROID TREATMENT AS MAIN INFLUENCING FACTORS IN THE PERCEPTION OF QUALITY OF LIFE IN ANCA-ASSOCIATED VASCULITIS: FINAL RESULTS FROM THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE
7. OP0304 BENRALIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): RESULTS FROM A EUROPEAN MULTICENTER STUDY ON 121 PATIENTS
8. AB0789 AVACOPAN IN THE REAL-LIFE PRACTICE: EVALUATION OF EFFICACY, SAFETY, AND IMPACT ON QUALITY OF LIFE IN THE EARLY STAGES OF TREATMENT
9. POS1176 HOSPITALIZATION RATES, FEATURES, AND DISCHARGE DIAGNOSES OF A LARGE NATIONWIDE COHORT OF ANCA-ASSOCIATED VASCULITIS
10. POS0729 DIFFERENCES BETWEEN GLUCOCORTICOIDS, CONVENTIONAL DMARDS AND TOCILIZUMAB IN ACHIEVING DISEASE REMISSION AND IN PREVENTING THE PROGRESSION OF DAMAGE IN GIANT CELL ARTERITIS PATIENTS
11. POS0708 VALIDATION OF THE REVISED 2022 AMERICAN COLLEGE OF RHEUMATOLOGY/ EULAR CLASSIFICATION CRITERIA FOR TAKAYASU ARTERITIS
12. AB0729 EVALUATION OF DIFFERENT TREATMENT REGIMENS IN TAKAYASU’S ARTERITIS: A SINGLE CENTER STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.